Home » Topics » Regulatory

Regulatory
RSS

Bayer will launch new quinolone on September 1

Aug. 13, 1999

Emdogain approved by FDA for minimally invasive dental surgery

Aug. 13, 1999

CPMP adopts positive opinion concerning reformulated Norvir capsules

Aug. 13, 1999

FDA further expands approved indications for Zocor

Aug. 11, 1999

Fujisawa announced setback in launch data for Protopic

Aug. 10, 1999

U.K.'s MCA is first to approve Synercid for marketing

Aug. 5, 1999

Diatide receives second major product approval in less than 12 months

Aug. 5, 1999

FDA approves Antagon for LH inhibition in women undergoing fertility treatment

July 30, 1999

Connetics seeks FDA approval of scalp dermatoses treatment

July 30, 1999

FDA approves SB's Kytril for prevention of radiation-induced nausea and vomiting

July 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.